Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples